A*STAR Singapore Immunology Network (A*STAR SIgN)

A*STAR scientists can now classify immune cell populations with greater precision thanks to a machine-learning algorithm.

A*STAR scientists have identified a molecular marker for tracing the origins of immune cells that reside in tissues and organs.

An imaging technique that distinguishes tumor-associated blood vessels from normal ones could pave the way for better clinical management of tumors.

A three-dimensional liver organoid model for studying dormant malaria parasites may pave the way for better antimalarial drugs.

By mapping the development trajectory of immune precursor cells, A*STAR scientists showed that plasmacytoid dendritic cells were incorrectly classified in the immune ‘family tree.’ 

Targeted mutagenesis is being used to create live-attenuated vaccines against the chikungunya virus.

A*STAR scientists have found a way to strengthen the immune response to adenovirus infection using engineered antibodies.

A gene variant more common among East Asians is responsible for milder symptoms and better outcomes during hepatitis B infection.

Researchers at A*STAR have developed a method to obtain a holistic view of the identities and proportions of immune cells in patient blood samples.

Different forms of the protein HNF4ɑ can pair up to influence diverse processes ranging from development to diabetes, study shows.

A*STAR researchers have identified four peptide sequences that distinguish the Zika virus from other flaviviruses, with implications for diagnostics and vaccine development.

The antiviral protein Viperin keeps immune cells in check to prevent joint swelling during chikungunya virus infection.